OPKO Health, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
OPKO Health, Inc. (OPK) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 640.85 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-04-28
- OPKO Health, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 640.85M shares, a 0.04% increase year-over-year.
- OPKO Health, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 640.76M shares, a 2.89% increase year-over-year.
- OPKO Health, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 640.70M shares, a 9.27% increase year-over-year.
- OPKO Health, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 640.58M shares, a 9.25% increase year-over-year.
- OPKO Health, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 640.66M shares, a 7.59% increase from fiscal 2019.
- OPKO Health, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 595.45M shares, a 5.74% increase from fiscal 2018.
- OPKO Health, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 563.14M shares, a 0.71% increase from fiscal 2017.
- OPKO Health, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 559.16M shares, a 1.51% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | 640.85M shares 10-Q · filed 2021-04-28 | 640.81M shares derived: average of 2 quarters · filed 2021-04-28 | 640.77M shares derived: average of 3 quarters · filed 2021-04-28 | 640.72M shares derived: average of 4 quarters · filed 2021-04-28 |
| 2020-12-31 | 640.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | 640.73M shares derived: average of 2 quarters · filed 2021-02-18 | 640.68M shares derived: average of 3 quarters · filed 2021-02-18 | 640.66M shares 10-K · filed 2021-02-18 |
| 2020-09-30 | 640.70M shares 10-Q · filed 2020-10-29 | 640.64M shares derived: average of 2 quarters · filed 2020-10-29 | 640.62M shares 10-Q · filed 2020-10-29 | 636.16M shares derived: average of 4 quarters · filed 2021-04-28 |
| 2020-06-30 | 640.58M shares 10-Q · filed 2020-07-31 | 640.58M shares 10-Q · filed 2020-07-31 | 634.64M shares derived: average of 3 quarters · filed 2021-04-28 | 622.57M shares derived: average of 4 quarters · filed 2021-04-28 |
| 2020-03-31 | 640.58M shares 10-Q · filed 2021-04-28 | 631.67M shares derived: average of 2 quarters · filed 2021-04-28 | 616.57M shares derived: average of 3 quarters · filed 2021-04-28 | 609.01M shares derived: average of 4 quarters · filed 2021-04-28 |
| 2019-12-31 | 622.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | 604.56M shares derived: average of 2 quarters · filed 2021-02-18 | 598.49M shares derived: average of 3 quarters · filed 2021-02-18 | 595.45M shares 10-K · filed 2021-02-18 |
| 2019-09-30 | 586.35M shares 10-Q · filed 2020-10-29 | 586.35M shares derived: average of 2 quarters · filed 2020-10-29 | 586.35M shares 10-Q · filed 2020-10-29 | 583.20M shares derived: average of 4 quarters · filed 2021-02-18 |
| 2019-06-30 | 586.35M shares 10-Q · filed 2020-07-31 | 586.35M shares 10-Q · filed 2020-07-31 | 582.16M shares derived: average of 3 quarters · filed 2021-02-18 | 576.56M shares derived: average of 4 quarters · filed 2021-02-18 |
| 2019-03-31 | 586.34M shares 10-Q · filed 2020-05-06 | 580.06M shares derived: average of 2 quarters · filed 2021-02-18 | 573.30M shares derived: average of 3 quarters · filed 2021-02-18 | 569.86M shares derived: average of 4 quarters · filed 2021-02-18 |
| 2018-12-31 | 573.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | 566.78M shares derived: average of 2 quarters · filed 2021-02-18 | 564.37M shares derived: average of 3 quarters · filed 2021-02-18 | 563.14M shares 10-K · filed 2021-02-18 |
| 2018-09-30 | 559.79M shares 10-Q · filed 2019-11-05 | 559.66M shares derived: average of 2 quarters · filed 2019-11-05 | 559.60M shares 10-Q · filed 2019-11-05 | 559.56M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | 559.54M shares 10-Q · filed 2019-08-07 | 559.51M shares 10-Q · filed 2019-08-07 | 559.49M shares derived: average of 3 quarters · filed 2020-03-02 | 559.47M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | 559.47M shares 10-Q · filed 2019-05-08 | 559.46M shares derived: average of 2 quarters · filed 2020-03-02 | 559.44M shares derived: average of 3 quarters · filed 2020-03-02 | |
| 2017-12-31 | 559.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 559.43M shares derived: average of 2 quarters · filed 2020-03-02 | 559.16M shares 10-K · filed 2020-03-02 | |
| 2017-09-30 | 559.41M shares 10-Q · filed 2018-11-09 | 559.07M shares 10-Q · filed 2018-11-09 | ||
| 2017-03-31 | 558.43M shares 10-Q · filed 2018-05-08 | 558.08M shares derived: average of 2 quarters · filed 2018-05-08 | 556.13M shares derived: average of 3 quarters · filed 2018-05-08 | |
| 2016-12-31 | 557.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 554.98M shares derived: average of 2 quarters · filed 2018-03-01 | 550.85M shares 10-K · filed 2018-03-01 | |
| 2016-09-30 | 552.23M shares 10-Q · filed 2017-11-08 | 548.55M shares 10-Q · filed 2017-11-08 | ||
| 2016-03-31 | 545.82M shares 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | 488.07M shares 10-K · filed 2018-03-01 | |||
| 2015-06-30 | 462.25M shares 10-Q · filed 2015-08-05 | 454.36M shares 10-Q · filed 2015-08-05 | 446.95M shares derived: average of 3 quarters · filed 2017-03-01 | 442.10M shares derived: average of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | 446.48M shares 10-Q · filed 2016-05-09 | 439.29M shares derived: average of 2 quarters · filed 2017-03-01 | 435.39M shares derived: average of 3 quarters · filed 2017-03-01 | 429.88M shares derived: average of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | 432.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | 429.84M shares derived: average of 2 quarters · filed 2017-03-01 | 424.34M shares derived: average of 3 quarters · filed 2017-03-01 | 422.01M shares 10-K · filed 2017-03-01 |
| 2014-09-30 | 427.58M shares 10-Q · filed 2014-11-07 | 420.46M shares derived: average of 2 quarters · filed 2015-08-05 | 418.65M shares 10-Q · filed 2014-11-07 | 415.85M shares derived: average of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | 413.34M shares 10-Q · filed 2015-08-05 | 413.13M shares 10-Q · filed 2015-08-05 | 411.93M shares derived: average of 3 quarters · filed 2016-02-29 | 399.11M shares derived: average of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | 412.91M shares 10-Q · filed 2015-05-11 | 411.23M shares derived: average of 2 quarters · filed 2016-02-29 | 394.37M shares derived: average of 3 quarters · filed 2016-02-29 | 379.96M shares derived: average of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | 409.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | 385.10M shares derived: average of 2 quarters · filed 2016-02-29 | 368.98M shares derived: average of 3 quarters · filed 2016-02-29 | 355.10M shares 10-K · filed 2016-02-29 |
| 2013-09-30 | 360.64M shares 10-Q · filed 2014-11-07 | 348.69M shares derived: average of 2 quarters · filed 2014-11-07 | 336.94M shares 10-Q · filed 2014-11-07 | 325.00M shares derived: average of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | 336.73M shares 10-Q · filed 2014-08-11 | 324.90M shares 10-Q · filed 2014-08-11 | 313.13M shares derived: average of 3 quarters · filed 2015-02-27 | 309.37M shares derived: average of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | 312.93M shares 10-Q · filed 2014-05-09 | 301.32M shares derived: average of 2 quarters · filed 2015-02-27 | 300.25M shares derived: average of 3 quarters · filed 2015-02-27 | |
| 2012-12-31 | 289.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | 293.91M shares derived: average of 2 quarters · filed 2015-02-27 | 295.75M shares 10-K · filed 2015-02-27 | |
| 2012-09-30 | 298.10M shares 10-Q · filed 2013-11-12 | 297.76M shares 10-Q · filed 2013-11-12 | ||
| 2011-12-31 | 280.67M shares 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |